These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1407880)

  • 21. Lung mechanics and gas exchange in ventilated preterm infants during treatment of hyaline membrane disease with multiple doses of artificial surfactant (Exosurf).
    Pfenninger J; Aebi C; Bachmann D; Wagner BP
    Pediatr Pulmonol; 1992 Sep; 14(1):10-5. PubMed ID: 1437337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surfactant for babies.
    Lancet; 1992 Dec; 340(8832):1387. PubMed ID: 1360097
    [No Abstract]   [Full Text] [Related]  

  • 23. Overview of clinical trials comparing natural and synthetic surfactants.
    Halliday HL
    Biol Neonate; 1995; 67 Suppl 1():32-47. PubMed ID: 7647157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Exosurf-Neonatal: the synthetic surfactant. Introductory symposium, 20 June 1992].
    Monatsschr Kinderheilkd; 1992 Sep; 140(9 [EXOSURF]):1-12. PubMed ID: 1406736
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages.
    Thomassen MJ; Meeker DP; Antal JM; Connors MJ; Wiedemann HP
    Am J Respir Cell Mol Biol; 1992 Sep; 7(3):257-60. PubMed ID: 1520490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One-year follow-up of 89 infants with birth weights of 500 to 749 grams and respiratory distress syndrome randomized to two rescue doses of synthetic surfactant or air placebo. Canadian Exosurf Neonatal Study Group. Canadian Exosurf Neonatal Follow-Up Group.
    Casiro O; Bingham W; MacMurray B; Whitfield M; Saigal S; Vincer M; Long W
    J Pediatr; 1995 May; 126(5 Pt 2):S53-60. PubMed ID: 7745512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant.
    Bhutani VK; Abbasi S; Long WA; Gerdes JS
    J Pediatr; 1992 Feb; 120(2 Pt 2):S18-24. PubMed ID: 1735846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delayed compliance increase in infants with respiratory distress syndrome following synthetic surfactant.
    Armsby DH; Bellon G; Carlisle K; Rector D; Baldwin R; Long W; Stevenson DK; Ariagno RL
    Pediatr Pulmonol; 1992 Dec; 14(4):206-13. PubMed ID: 1484754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elastase activity and surfactant protein concentration in tracheal aspirates from neonates receiving synthetic surfactant.
    Gerdes J; Whitsett J; Long W
    J Pediatr; 1992 Feb; 120(2 Pt 2):S34-9. PubMed ID: 1735850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary hemorrhage in premature infants after treatment with synthetic surfactant: an autopsy evaluation. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    van Houten J; Long W; Mullett M; Finer N; Derleth D; McMurray B; Peliowski A; Walker D; Wold D; Sankaran K
    J Pediatr; 1992 Feb; 120(2 Pt 2):S40-4. PubMed ID: 1735851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of surfactant, lung compliance, and aeration of preterm rabbit lungs after surfactant therapy and conventional and high-frequency oscillatory ventilation.
    Heldt GP; Merritt TA; Golembeski D; Gilliard N; Bloor C; Spragg R
    Pediatr Res; 1992 Mar; 31(3):270-5. PubMed ID: 1561014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants.
    Hall SB; Venkitaraman AR; Whitsett JA; Holm BA; Notter RH
    Am Rev Respir Dis; 1992 Jan; 145(1):24-30. PubMed ID: 1731593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of the acute response to surfactant therapy by pulmonary function testing.
    Wallenbrock MA; Sekar KC; Toubas PL
    Pediatr Pulmonol; 1992 May; 13(1):11-5. PubMed ID: 1589306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-year follow-up of 66 premature infants weighing 500 to 699 grams treated with a single dose of synthetic surfactant or air placebo at birth: results of a double-blind trial. American Exosurf Neonatal Study Group I.
    Walther FJ; Mullett M; Schumacher R; Sundell H; Easa D; Long W
    J Pediatr; 1995 May; 126(5 Pt 2):S13-9. PubMed ID: 7745506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health and neurodevelopmental outcome at 1-year adjusted age in 508 infants weighing 700 to 1100 grams who received prophylaxis with one versus three doses of synthetic surfactant. American Exosurf Neonatal Study Groups I and II.
    Gerdes J; Gerdes M; Beaumont E; Cook L; Dhanireddy R; Kopleman A; Jarret R; Long W
    J Pediatr; 1995 May; 126(5 Pt 2):S26-32. PubMed ID: 7745508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing surfactant products.
    Prevost RR
    Clin Pharm; 1991 Dec; 10(12):909, 911. PubMed ID: 1773577
    [No Abstract]   [Full Text] [Related]  

  • 37. One-year follow-up of 273 infants with birth weights of 700 to 1100 grams after prophylactic treatment of respiratory distress syndrome with synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I.
    Sell M; Cotton R; Hirata T; Guthrie R; LeBlanc M; Mammel M; Long W
    J Pediatr; 1995 May; 126(5 Pt 2):S20-5. PubMed ID: 7745507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Artificial surfactant attenuates hyperoxic lung injury in primates. II. Morphometric analysis.
    Piantadosi CA; Fracica PJ; Duhaylongsod FG; Huang YC; Welty-Wolf KE; Crapo JD; Young SL
    J Appl Physiol (1985); 1995 May; 78(5):1823-31. PubMed ID: 7649918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artificial surfactant attenuates hyperoxic lung injury in primates. I. Physiology and biochemistry.
    Huang YC; Sane AC; Simonson SG; Fawcett TA; Moon RE; Fracica PJ; Menache MG; Piantadosi CA; Young SL
    J Appl Physiol (1985); 1995 May; 78(5):1816-22. PubMed ID: 7649917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Turnover of exogenous artificial surfactant.
    Ashton MR; Postle AD; Hall MA; Austin NC; Smith DE; Normand IC
    Arch Dis Child; 1992 Apr; 67(4 Spec No):383-7. PubMed ID: 1586175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.